Share gains for its cough and cold portfolio and strong demand for probiotics helped to drive up Recordati Industria Chimica & Farmaceutica SPA’s OTC sales at a double-digit rate in 2023.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
